From: Identification and validation of the methylation biomarkers of non-small cell lung cancer (NSCLC)
 | AMP a (NSCLC) | AMP (Control) | P value b | log 10 (OR) (95% CI) | P value c | Sen d | Spe d | AUC d |
---|---|---|---|---|---|---|---|---|
AGTR1 | 12.88% | 4.48% | 1.06 × 10-7 | 3.49 (2.08, 4.91) | 1.30 × 10-6 | 59.73% | 79.59% | 0.71 |
GALR1 | 18.31% | 2.91% | 6.58 × 10-9 | 2.56 (1.5, 3.63) | 2.30 × 10-6 | 46.98% | 85.03% | 0.67 |
NTSR1 | 9.37% | 0.56% | 1.09 × 10-9 | 9.02 (5.48, 12.55) | 5.90 × 10-7 | 44.30% | 94.56% | 0.70 |
SLC5A8 | 25.59% | 11.66% | 4.77 × 10-12 | 3.80 (2.51, 5.09) | 7.80 × 10-9 | 52.35% | 88.44% | 0.67 |
ZMYND10 | 6.95% | 12.82% | 1.08 × 10-7 | -4.61 (-6.27, -2.95) | 5.20 × 10-8 | 73.15% | 92.52% | 0.80 |
LINE-1 | 72.10% | 76.76% | 2.39 × 10-12 | -10.3 (-13.5, -7.2) | 1.80 × 10-10 | - | - | - |
Referencee | 1.78% | 1.83% | 2.85 × 10-1 | -19.37 (-45.35, 6.62) | 0.14 | - | - | - |